Assessment of the health status, consumption patterns and subjective benefits of medical cannabis in a sample of Catalan patients with chronic illnesses
Authors:
Daniel F. Jiménez-Garrido, Genís Oña, Pep Cura, Alícia Parès, Beatriz Aparecida Passos Bismara Paranhos, Felipe de Almeida Mendes, Mauricio Yonamine, Rafael G. dos Santos, Jaime E.C. Hallak, Miguel Ángel Alcázar-Córcoles, and José Carlos Bouso.
Journal:
Circular Farmacéutica
Year:
2021
About the study
This cross-sectional study describes the social and health realities of a sample of Catalan therapeutic cannabis users with chronic illnesses, with the aim that professional pharmacists and other health professionals can learn in detail how this practice works.
The recruitment of participants with chronic illnesses was carried out through different associations of patients who use cannabis and among cannabis clubs where we left information sheets about the study with the contact of ICEERS, who collaborates actively with the Department of Health of the Generalitat de Catalunya in training and research aspects related to the phenomenon of Cannabis Social Clubs.
In conclusion, there is a wide range of patients who use cannabis to alleviate some symptoms of chronic conditions, mainly related to inflammation and pain. After starting to use cannabis, patients abandon some prescription drugs and the number of visits to the emergency room or hospital stays decreases, circumstances that can lead to an improvement in quality of life and significant savings for public health systems.
Abstract
Not available.
Excerpt: Medical cannabis in chronic illnesses
“We designed a semi-structured interview with 27 items grouped into four categories: sociodemographic information, health indicators from the Health Survey of Catalonia (ESCA) and the General Health Questionnaire-12 (GHQ-12) scale, cannabis use and, finally, a retrospective health questionnaire referring to subjective general health items, mental well-being, use of emergency services or hospitalisation and total or partial substitution of some medication as if the response had been 12 months before starting to use cannabis.”
Categories:
Studies & papers
, Cannabis
Tags:
cannabis
, scientific research
, study
, therapeutic
, medical cannabis
, epidemiology
, chronic disease